Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Clinical and Experimental Immunology
|
December 25, 2009
Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes
S Marin-Gallen, X Clemente-Casares, R Planas, et al.
Journal of Hepatology
|
January 1, 1997
Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes
J M Llovet, P Rodríguez-Iglesias, E Moitinho, et al.
Revista Espanola De Enfermedades Digestivas
|
January 23, 2009
[Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry]
M García-Cortés, Y Borraz, M I Lucena, et al.
Journal of Hepatology
|
July 25, 2000
Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C
M Guilera, X Forns, X Torras, et al.
Actas Dermo-Sifiliograficas
|
December 3, 2014
Drug eruptions induced by telaprevir in patients with chronic hepatitis C virus genotype 1 infection: a prospective study
M Toro Montecinos, J M Carrascosa Carrillo, M Vilavella Rius, et al.
Gastroenterology
|
October 19, 2001
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers
J C García-Pagán, C Villanueva, M C Vila, et al.
Gastroenterology
|
October 1, 1996
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis
M Navasa, A Follo, J M Llovet, et al.
Alimentary Pharmacology & Therapeutics
|
November 30, 2016
Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO)
M Buti, J L Calleja, S Lens, et al.
Gut
|
April 1, 1996
Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial
J M Sánchez-Tapias, X Forns, S Ampurdanés, et al.
Gastroenterology
|
October 1, 1996
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis
A Ginès, G Fernández-Esparrach, A Monescillo, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Clinical and Experimental Immunology
|
December 25, 2009
Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes
S Marin-Gallen, X Clemente-Casares, R Planas, et al.
Journal of Hepatology
|
January 1, 1997
Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes
J M Llovet, P Rodríguez-Iglesias, E Moitinho, et al.
Revista Espanola De Enfermedades Digestivas
|
January 23, 2009
[Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry]
M García-Cortés, Y Borraz, M I Lucena, et al.
Journal of Hepatology
|
July 25, 2000
Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C
M Guilera, X Forns, X Torras, et al.
Actas Dermo-Sifiliograficas
|
December 3, 2014
Drug eruptions induced by telaprevir in patients with chronic hepatitis C virus genotype 1 infection: a prospective study
M Toro Montecinos, J M Carrascosa Carrillo, M Vilavella Rius, et al.
Gastroenterology
|
October 19, 2001
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers
J C García-Pagán, C Villanueva, M C Vila, et al.
Gastroenterology
|
October 1, 1996
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis
M Navasa, A Follo, J M Llovet, et al.
Alimentary Pharmacology & Therapeutics
|
November 30, 2016
Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO)
M Buti, J L Calleja, S Lens, et al.
Gut
|
April 1, 1996
Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial
J M Sánchez-Tapias, X Forns, S Ampurdanés, et al.
Gastroenterology
|
October 1, 1996
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis
A Ginès, G Fernández-Esparrach, A Monescillo, et al.
Page
of 13